26 completed. 26 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 26 | Completed 26 |
Follow Neuroectodermal Tumors: new trials by email Literature Review of Neuroectodermal Tumors trials Research Report on Neuroectodermal Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy Assessment, Questionnaire Administration, Telemedicine Visit - Astrocytoma, IDH-Mutant, Glioblastoma | Phase 4 | Completed | Mayo Clinic | 30 | 2024-10-07 | 2026-04-29 |
| Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients arginine/lysine - Gastroenteropancreatic Neuroendocrine Tumors | Phase 4 | Completed | Advanced Accelerator Applications | 42 | 2021-01-25 | 2025-01-24 |
| Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593) Pembrolizumab - Carcinoma, Non-Small-Cell Lung, Melanoma | Phase 4 | Completed | Merck Sharp & Dohme LLC | 150 | 2019-01-31 | 2025-08-29 |
| A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide Octreotide, LAR Lanreotide, Questionnaires - Neuroendocrine Tumors | Phase 4 | Completed | Memorial Sloan Kettering Cancer Center | 51 | 2017-09-19 | 2025-05-09 |
| Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study Propofol, isoflurane, sevoflurane or desflurane - Cancer, Breast, Cancer Colorectal | Phase 4 | Completed | Peter MacCallum Cancer Centre, Australia | 169 | 2017-08-27 | 2022-06-09 |
| Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream 5-aminolevulinic acid nanoemulsion - Lentigo Maligna | Phase 4 | Completed | Joint Authority for Päijät-Häme Social and Health Care | 10 | 2016-02-01 | 2018-05-30 |
| Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma GM-CSF, Standard of Care - Melanoma | Phase 4 | Completed | Mayo Clinic | 8 | 2015-05-01 | 2020-02-10 |
| Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies blood sampling, Nivolumab - Metastatic Melanoma | Phase 4 | Completed | Hospices Civils de Lyon | 32 | 2015-04-23 | 2025-09-15 |
| Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients lanreotide acetate - NeuroEndocrine Tumours | Phase 4 | Completed | Ipsen | 50 | 2014-05-01 | 2019-06-07 |
| An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma Zelboraf - Malignant Melanoma | Phase 4 | Completed | Hoffmann-La Roche | 60 | 2013-10-17 | 2020-01-07 |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Pasireotide, Cabergoline, Pasireotide LAR - Cushing's Disease, Acromegaly | Phase 4 | Completed | RECORDATI GROUP | 337 | 2013-06-10 | 2024-10-01 |
| Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. Everolimus, Sandostatin LAR Depot - Neoplasms | Phase 4 | Completed | Novartis Pharmaceuticals | 34 | 2013-05-14 | 2021-06-11 |
| To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer 300mg vandetanib, 150mg vandetanib - Thyroid Cancer | Phase 4 | Completed | Sanofi | 81 | 2012-06-08 | 2025-10-03 |
| A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors sunitinib - Well-differentiated Pancreatic Neuroendocrine Tumor | Phase 4 | Completed | Pfizer | 106 | 2012-06-06 | 2019-07-30 |
| Phenoxybenzamine Versus Doxazosin in PCC Patients Phenoxybenzamine, Doxazosin - Pheochromocytoma | Phase 4 | Completed | University Medical Center Groningen | 134 | 2011-12-01 | 2024-09-19 |
| An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1) Everolimus (RAD001) - Neuroendocrine Tumors | Phase 4 | Completed | Novartis Pharmaceuticals | 246 | 2011-04-27 | 2018-11-29 |
| RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation RAD001, Paclitaxel, Carboplatin - Carcinoma, Large Cell, Neuroendocrine Tumors | Phase 4 | Completed | Novartis Pharmaceuticals | 49 | 2011-04-01 | 2016-03-30 |
| Effect of Topical Imiquimod on Lentigo Maligna Imiquimod - Lentigo Maligna | Phase 4 | Completed | Jerry Marsden | 30 | 2010-06-01 | 2012-06-20 |
| CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma carboplatin periocular injection, CEV chemotherapy - Retinoblastoma | Phase 4 | Completed | Sun Yat-sen University | 26 | 2009-01-01 | 2015-03-30 |
| Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma Aldesleukin - Metastatic Renal Cell Carcinoma, Metastatic Melanoma | Phase 4 | Completed | Novartis Pharmaceuticals | 26 | 2008-09-03 | 2021-06-08 |
Showing 20 of 26. Sign in to see all of them.
Melanoma (10) · Neuroendocrine Tumors (8) · Neoplasms (4) · Brain Neoplasms (2) · Carcinoid Tumor (2) · Carcinoma (2) · Glioblastoma (2) · Hutchinson's Melanotic Freckle (2) · Lung Neoplasms (2) · Neoplasm Metastasis (2) · Pheochromocytoma (2) · Prostatic Neoplasms (2) · Retinoblastoma (2) · Acromegaly (1) · Adenoma (1)
Neoplasms by Histologic Type (26) · Neoplasms, Germ Cell and Embryonal (26) · Neoplasms, Nerve Tissue (26) · Neoplasms (22) · Neoplasms by Site (16) · Neuroendocrine Tumors (14) · Neoplasms, Glandular and Epithelial (12) · Nevi and Melanomas (12) · Skin Diseases (10) · Skin Neoplasms (10) · Skin and Connective Tissue Diseases (10) · Carcinoma (6) · Adenocarcinoma (4) · Endocrine Gland Neoplasms (4)
Everolimus (3) · Carboplatin (2) · Octreotide (2) · Temozolomide (2) · Aminolevulinic Acid (1) · BF-200 ALA (1) · Blood Specimen Collection (1) · Cabergoline (1) · Craniotomy (1) · Desflurane (1) · Doxazosin (1) · Etanercept (1) · Etoposide (1) · Fibrin Tissue Adhesive (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1)
Novartis Pharmaceuticals (4) · Mayo Clinic (2) · Merck Sharp & Dohme LLC (2) · Advanced Accelerator Applications (1) · Hoffmann-La Roche (1) · Hospices Civils de Lyon (1) · Ipsen (1) · Jagiellonian University (1) · Jerry Marsden (1) · Joint Authority for Päijät-Häme Social and Health Care (1) · Memorial Sloan Kettering Cancer Center (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Oxford University Hospitals NHS Trust (1) · Peter MacCallum Cancer Centre, Australia (1) · Pfizer (1)
United States (10) · Italy (5) · Netherlands (5) · India (4) · Poland (4) · United Kingdom (4) · Czechia (3) · France (3) · Germany (3) · Russia (3) · South Korea (3) · Spain (3) · Australia (2) · Belgium (2) · Hungary (2)
A A. Franken, MD PhD (1) · Bas Havekes, MD PhD (1) · Boni E Elewski, MD (1) · C B. Brouwer, MD PhD (1) · E M. Eekhoff, MD PhD (1) · Erna Snellman, Professor (1) · G D. Valk, MD PhD (1) · H R Haak, MD PhD (1) · Henk P. Giele, MBBS FRACS (1) · Huasheng Yang, M.D, PHD (1) · I Eland, MD PhD (1)
PMID 21319349, PMID 21456091, PMID 25243546, PMID 26481741, PMID 27875519, PMID 28535181, PMID 31714582, PMID 33411058, PMID 35132704, PMID 35724357, PMID 38939518, PMID 41567708
2019 (1)